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ABSTRACT
Mouse embryonic stem cells (mESCs) cultured
with MEK/ERK and GSK3 (2i) inhibitors transi-
tion to ground state pluripotency. Gene expression
changes, redistribution of histone H3K27me3 pro-
files and global DNA hypomethylation are hallmarks
of 2i exposure, but it is unclear whether epige-
netic alterations are required to achieve and main-
tain ground state or occur as an outcome of 2i sig-
nal induced changes. Here we show that ESCs with
three epitypes, WT, constitutively methylated, or hy-
pomethylated, all undergo comparable morphologi-
cal, protein expression and transcriptome changes
independently of global alterations of DNA methyla-
tion levels or changes in H3K27me3 profiles. Dazl and
Fkbp6 expression are induced by 2i in all three epi-
types, despite exhibiting hypermethylated promot-
ers in constitutively methylated ESCs. We identify
a number of activated gene promoters that undergo
2i dependent loss of H3K27me3 in all three epitypes,
however genetic and pharmaceutical inhibition ex-
periments show that H3K27me3 is not required for
their silencing in non-2i conditions. By separating
and defining their contributions, our data suggest
that repressive epigenetic systems play minor roles
in mESC self-renewal and naı¨ve ground state estab-
lishment by core sets of dominant pluripotency asso-
ciated transcription factor networks, which operate
independently from these epigenetic processes.
INTRODUCTION
Mouse embryonic stem cells (mESCs) can be derived from
the inner cell mass (ICM) of blastocysts following their in
vitro culture (1,2). Culture medium developed for mESCs
contains leukemia inhibitory factor (LIF) in the presence
of serum or bone morphogenetic protein 4, which in-
duces phosphorylation and activation of downstream tran-
scription factors Stat3 and Smad1 (3,4). Cultured mESCs
have considerable self-renewing capacity via expression of
pluripotency genes that maintain their identity; they can
contribute to germline chimeras and can differentiate into
all three primary germ layers in vitro (5). Pluripotency in
mESCs depends upon the coordinated action of a gene reg-
ulatory network assembled from transcription factors (e.g.
Oct4, Sox2, Nanog: the OSN network), which is subject
to modulation by multiple signalling pathways in response
to environmental cues that support self-renewal or initi-
ate differentiation (6,7). Under serum/LIF (serum) cultur-
ing conditions, a fine balance between renewal and pro-
differentiation signals results in populations of mESCs that
are heterogeneous and metastable, exhibiting a dynamic
equilibrium in expression states for several pluripotency
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factors (8). Importantly, during the process of derivation
of mESCs from pre-implantation stage embryos the cells
adopt mature heterochromatin and DNA/histone modifi-
cations that deviate from their in vivo ICM counterparts (9).
Overall, the cellular and chromatin identity of mESCs in
serum cultures partly resembles that of ICM cells, epiblast
cells and germ cells (10,11).
Culturing mESCS in 2i/LIF conditions containing in-
hibitors of MEK/ERK and GSK3 leads to a more ho-
mogeneous population, which more closely resemble ICM
cells in terms of gene expression and epigenetic signatures,
termed the naı¨ve ground state (11). Transfer ofmESCs from
serum to 2i conditions consolidates developmental naı¨vety
by endowing these cells with additional pluripotency fea-
tures (12). These include enhanced Nanog and Klf2 ex-
pression and epigenetic changes, such as global DNA hy-
pomethylation and redistribution of H3K27me3 (a repres-
sive histone modification mark) from bivalent CpG island
promoters (13). It has been proposed that 2i conversion of
mESCs represents a remodelling of the epigenome in con-
cert with a reconfiguration of the gene regulatory network,
which enables unbiased developmental plasticity (14).
Although DNA methylation is essential for the mat-
uration of an embryo, it is striking that globally hy-
pomethylated mESCs lacking de novo and maintenance cy-
tosine methyltransferases cultured in serum grow robustly
and self-renew (15–17). TKO (Dnmt3a−/−, Dnmt3b−/−;
Dnmt1−/−) cells express typical markers of pluripotency
(Oct4, Rex1, Fgf4 and Nanog) to the same extent as their
wild-type (WT) J1 counterparts, strongly suggesting that
DNA methylation is dispensable for mESC maintenance.
Lack of DNA methylation restricts the capacity of these
cells to differentiate into early embryonic stages but is per-
missive for extraembryonic lineages in vivo (18). Transcrip-
tional repression associatedwithDNAmethylation is essen-
tial for maintaining somatic cell fates and identity (18,19).
In serum cultures, different pluripotent states defined by
high-low expression states of Stella, Nanog and Rex1, re-
spectively, are correlated with the relative global methyla-
tion status of mESCs. This suggests a potential role for
DNA methylation in the generation and maintenance of
variability in stem cell populations (8,13,20). However, the
direct contribution of DNA hypomethylation in driving
mESCs to a naı¨ve gene expression pattern is still unclear.
In addition, the subsequent global redistribution of re-
pressive H3K27me3 marks observed in hypomethylated 2i
mESCs may be causally required to stabilize and maintain
the ground state, or it may be an indirect consequence of
decreased DNA methylation levels (13).
To explore the potential contributions of DNA methy-
lation in relation to mESC identity and stability in serum
and 2i cultures, we compared the response of WT mESCs
with either constitutively hypomethylated or constitutively
methylated mESCs. We observed a similar response in cell
morphology, attainment of uniform expression of pluripo-
tency genes (Nanog and Esrrb) and deep silencing of differ-
entiation genes. We identified a set of core transcriptional
changes that occur in the transition to 2i in all three epi-
types, suggesting that these changes affect signalling regu-
lated genes and occur independently of DNA methylation
state in mESCs. In addition, we identified a subset of CpG
island genes that undergo signal-induced transcriptional
changes that coincide with a depletion of H3K27me3 in all
three cell types under 2i conditions, however, H3K27me3 is
not required for their silencing in serum cultured mESCs.
Our data suggest that altered patterns of DNAmethylation
and H3K27me3 do not define naive state identity, which
is primarily dictated by transcriptional and signalling net-
works. Instead these epigenetic transitions may be part of
dynamic chromatin state changes prior to differentiation,
when epigenetic regulatorymechanisms have a role in defin-
ing gene expression states (21). This general conclusion is
in broad agreement with recent work that studied the im-
pact of PRC2 function in the transition of mESCs to a 2i
ground state, in which loss of Eed (a PRC2 component)
to prevent H3K27me3 deposition had a minimal effect on
the 2i transcriptome, implying that it is largely dispensable
for establishment of the ground state (22,23). This chimes
with our recent work showing that although DNA methy-
lation has a role in shaping major aspects of PRC directed
3D genome organization in mESCs, this also does not con-
tribute to maintenance of the 2i ground state (24).
MATERIALS AND METHODS
Cell culture
All cell lines used were generated from male WT J1 mESCs
that were originally derived from the 129S4/SvJae strain,
except Dnmt1tet/tet cells, derived from R1 mESCs. mESCs
were cultured in serum conditions as previously described
(24,25), except ESGRO LIF (Millipore) was used at 500
U/ml for all lines apart fromDnmt1tet/tetmESCs which were
cultured at 1000 U/ml. WT J1 mESCs were grown on Mit-
omycin C inactivated SNLP feeder cells in serum cultures,
all other cell lines were grown feeder free on 0.2% gelatin-
coated flasks. 2i culturing conditions were as previously de-
scribed (24,25); inhibitors were used at 1 M PD0325901
(MEK inhibitor, Stemgent) and 3 MCHIR99021 (GSK3
inhibitor, Stemgent) and ESGRO LIF was used at 1000
U/ml. Doxycycline-inducible Prdm14 overexpressing TKO
cells were established by transfecting PB-TET-FlagPrdm14-
IRES-Neo, PB-CArtTA Adv, pCAG-Pbase and pGG131
(pCAG-DsRed-IRES-Hygro) (26) into TKO cells using Fu-
gene 6 HD (Promega) followed by sorting red cells using a
BD FACSAria flow cytometer; single cell clones were ex-
panded and characterised. KOVI-3l and 3B3l mESCs were
generated as described in McLaughlin et al. 24.Dnmt1tet/tet
doxycycline regulateable mESCs were a gift from R. Chail-
let lab, for derivation procedure see Borowczyk et al. (27).
Dnmt1tet/tet doxycycline regulateable mESCs were treated
with 10M EPZ6438 (EZH2 inhibitor) for 9 days.
siRNA knockdown
RNAiMAX (ThermoFisher) was used to transfect 2× 10∧5
mESCs/6 well and 1 × 105 mESCs per 12-well (on cover-
slips coated with 0.2% gelatin) with 50 nM siRNATet1 plus
50 nM siRNA Tet2 or 100 nM scrambled siRNA (see Sup-
plementary information, Table S1 for sequences). mESCs
were cultured post transfection in either serum for 72 or 48
h in serum followed by 24 h in 2i; medium was changed ev-
ery day.
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Embryoid body differentiation
mESCs were detached with trypsin and spun down prior to
resuspension in mESC basal medium with 20% FCS and
plating as 200 cells/20 l as hanging drop cultures. After 2
days cells aggregated and EBs were cultured in suspension
in mESC basal medium for 3 days prior to 3–6 days of ad-
herent culture on 0.2% gelatin on glass coverslips. Patches
of cardiomyocytes were recorded, and EBs were fixed with
4% PFA for 15 min and stored at 4◦C covered in PBS prior
to staining.
Differentiation to epiblast stem cells
6× 104 mESCs/six-well were seeded in standard serum con-
ditions on human fibronectin (Millipore, FC010) for 24 h
and subsequently cultured in EpiSC culture medium sup-
plemented with N2 (Gibco, 17502048) and B27 (Gibco,
17504044) consisting of a 1:1 mixture of DMEM F-
12 (Thermo Fisher, 21331020) and Neurobasal medium
(Thermo Fisher, 21103049), 0.1 mM non-essential amino
acids (SIGMA), 2 mM L-glutamine, 0.1 mM beta mer-
captoethanol (Thermo Fisher), Activin A (Peprotech, 120-
14E) at 20 ng/ml and FGF2 (R&D systems, 3139-FB) at
10 ng/ml. Cells were passaged every 3–5 days with accutase
(Gibco, A1110501) and reseeded as clusters of cells at 4 ×
104 cells/six-well, which resulted in a stable Epiblast stem
cell line after several passages.
RT-qPCR
Total RNA was extracted using an RNeasy kit (Qiagen),
following manufacturer’s protocol and using Qiashredder
columns (Qiagen) to homogenize the samples and RNase
free DNase kit (Qiagen) to perform DNA digestion. 1 g
RNA was converted to cDNA using random primers
(Promega) and Superscript III (Thermo Fisher) following
manufacturer’s protocol. qPCR reactions with gene specific
primers (see Supplementary Table S1) were carried out us-
ing SYBR green (Roche or Thermo Fisher) on a Lightcy-
cler 480 System II (Roche). TBP was used for normalisa-
tion; relative quantification was done by the 2-dCt method.
Three biological replicates were used for statistics and stan-
dard deviation was calculated to generate error bars follow-
ing MIQE guidelines (Supplementary Table S3).
Western blotting
Protein was extracted using RIPA buffer (Thermo Fisher)
supplemented with protease inhibitor cocktail (Roche) fol-
lowed by boiling in 1× LDS sample buffer and 1× reduc-
ing reagent (both Thermo Fisher) for 5 min at 95◦C. 30, 15
or 7.5 g of protein was loaded per sample and run in 4–
12% Bis–Tris gels (Thermo Fisher) in 1× MOPS or MES
buffer (Thermo Fisher). Dry blotting was performed using
an iBlot™ device (Thermo Fisher) and PVDF iBlot™ gel
transfer stacks. Membranes were blocked in 0.1% Tween-
20 in PBS with 1:10 dilution of western blocking reagent
(Thermo Fisher) for a minimum of 45 min at room tem-
perature followed by primary antibody incubation at 4◦C
overnight and secondary antibody incubation for 1 h at
room temperature (for antibodies and dilutions see; sup-
plementary information, Table S2). HRP stained western
blots were developed using SuperSignal West Pico Chemi-
luminescent substrate (Thermo Scientific) and imaged using
an ImageQuant LAS 4000 (GE Healthcare). Near infrared
stained blots were imaged on an Odyssey Fc system (LI-
COR, Nebraska, USA).
Immunocytochemistry
mESCs on glass coverslips coated with gelatin were stained
using standard immunocytochemistry protocols. Briefly,
mESCs were fixed with 4% PFA, 10 min and incubated
overnight with primary antibodies (see; supplementary in-
formation, Table S2) at 4◦C, followed by incubation with
appropriate Alexafluor-conjugated secondary antibodies
(Thermo Fisher) at room temperature for 1 h. Nuclei
were labelled using DAPI (4′,6-diamidino-2-phenylindole).
Imaging was done using a Zeiss Axioscope 2 microscope
with Zeiss optics or a Nikon A1 Confocal system with Zeiss
optics. Embryos were stained following procedure previ-
ously described (9). Briefly, blastocyst stage embryos were
fixed in 4% PFA overnight at 4◦C followed by permeabi-
lization in 0.2% Triton X-100 (Sigma-Aldrich) in PBS for
30 min and two washes with PBS-0.01% Tween (Sigma-
Aldrich; PBST) prior to blocking with 5% donkey serum
(Sigma-Aldrich) in PBST for 2 h at room temperature. Pri-
mary antibodies (see; supplementary information, Table S2)
were incubated overnight at 4◦C in 1% donkey serum in
PBS, followed by three washes in PBST. Secondary anti-
bodies conjugated to either FITC or TRITC (Jackson Lab-
oratories) were used at 1:200 for 1 h at room tempera-
ture, followed by washes. Samples were counterstained with
DAPI in Vectashield mounting medium (Vectashield). Im-
ages were captured with a Zeiss laser confocal microscope
(LSM510 Meta) and LSM software.
Alkaline phosphatase staining
Alkaline phosphatase staining was performed using Al-
kaline phosphatase staining kit II (Stemgent) according
to manufacturer’s instructions and imaged using a Nikon
Eclipse Ti-S microscope.
Methylation analysis
Genomic DNA was extracted using DNeasy Blood and
Tissue kit (Qiagen) following manufacturer’s protocol or
standard phenol chloroform precipitation and eluted in wa-
ter. DNA was treated with RNase A/T1 Cocktail (Am-
bion) overnight at 37◦C followed by ethanol precipitation.
Quantitation of 5mC in genomic DNA was done by iso-
cratic high performance reverse phase liquid chromatogra-
phy (HPLC) as previously described (28) with the follow-
ing alterations. A Dionex UM 3000 HPLC system was used
complete with a column chiller, C18 column (250 mm× 4.6
mm 5MAPEXODS,GraceDiscovery Sciences), and col-
umn guard (Phomenex). The mobile phase was 50 mM am-
momium phosphate (monobasic) pH4.1. The column was
chilled to 8◦C to improve peak separation. Deoxyribonu-
cleotides (dNMPs)were detected at their extinctionmaxima
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using a Dionex 3000 multiple wavelength detector: dCMP,
276 nm; 5mdCMP, 282 nm. Quantifications were calculated
from the area under each peak using the respective extinc-
tion coefficients (dCMP, 8.86 × 103; 5mdCMP 9.0 × 103).
Bisulfite sequencing
Bisulfite sequencing was carried out as described (29). For
details of primers utilised see; Supplementary information,
Table S1. Bisulfite conversion of DNA was performed us-
ing the EZ-DNA methylation gold kit (ZymoResearch),
products were cloned into pGEM-T Easy (Promega) and
minimum 24 clones were picked per condition for plasmid
preparation followed by sequencing using BigDye, version
3.1 chemistry (Thermo Fisher). Bisulfite sequencing DNA
methylation analysis (BISMA) was used to calculate per-
cent methylation in bisulfite sequencing reads.
Agilent expression array and data analysis
Total RNAwas isolated usingRNeasy kit (Qiagen) andCy3
labelled aRNA was prepared using an Amino Allyl Mes-
sageAmp II aRNA kit (Ambion). Samples were hybridised
to SurePrint G3 mouse GE 8 × 60k microarrays (Agilent)
and scanned using NimbleGen MS200 (Roche). Results
were analysed with custom-written scripts implemented in
R (http://www.R-project.org). Differential expression was
calculated using the Bioconductor package linear models
for microarray data (limma v3.20.8). P-values were cor-
rected for multiple testing using the Benjamini–Hochberg
test and probes with P < 0.05 were deemed significant.
meDIP
meDIP was carried out as described (30). In short, 20 g
of genomic DNA was diluted in TE to 400 ul and soni-
cated using a Covaris plus sonicator to 150–700 bp range
with a mean of 300 bp. 6 g of fragmented DNA was di-
luted to 450 l in TE and denatured by incubation in a
thermoshaker for 10 min at 99◦C. 10% of the sample was
taken at this stage as an input fraction and stored at 4◦C.
Samples were incubated with 15 l of 5mC antibody (Eu-
rogentec) overnight at 4◦C. M280 Dynabeads were used for
immunoprecipitation.DNAwas purified using a PCR clean
up kit (Qiagen) and samples were eluted into 20 l; 10 l
was subjected to whole genome amplification using a SE-
QXE WGA kit (SIGMA) per manufacturer’s instructions,
except no SYBR green was added at the amplification step
and samples were amplified for a total of 18 cycles at which
point the volume required to get 2.1g of the lowest sample
was the volume used from each sample for further primer
removal and clean up using a PCR clean up kit (Qiagen).
We performed proton sequencing on libraries made from
100 ng of DNA per sample, using the Ion XpressPlus Frag-
ment Library Kit (Thermo Fisher). DNAwas end repaired,
purified, ligated to Ion-compatible barcoded adapters (Ion
Xpress™ Barcode Adapters 1–96, Thermo Fisher), followed
by nick-repair to complete the linkage between adapters
and DNA inserts. The adapter-ligated library was then am-
plified (10 cycles) and size-selected using two rounds ofAM-
Pure XP bead (Beckman Coulter) capture to obtain frag-
ments of ∼100–250 bp. Samples were then pooled at a 1:1
ratio and sequenced on an Ion Proton P1 microwell chip
(Thermo Fisher).
RNA sequencing
Total RNAwas extracted frommESCs using anRNeasy kit
(Qiagen). RNA was analysed using a bioanalyser and con-
firmed to be aboveRIN9. Samples were treatedwithDNase
(Ambion), and sample integrity verified on the Agilent Bio-
analyser with the RNANano-chip. Illumina Tru-seq paired
end strand specific sequencing (Illumina, USA) was car-
ried out on a NextSeq-550 sequencer (EdinburghWellcome
trust Clinical Research Facility, Western General Hospital,
Edinburgh, UK). 500 ng of Total RNA underwent riboso-
mal RNA depletion prior to purification (EPZ6438 treated
Dnmt1tet/tet mESCs) or PolyA-selection (J1, TKO and 3B3l
mESCs), fragmentation, random hexamer cDNA genera-
tion and purification with AMPure XP beads (Beckman-
Coulter, USA). Multiple indexing adapters were ligated to
ds cDNA with subsequent hybridisation onto flow cells,
and DNA fragment enrichment by 15 cycle PCR for se-
quencing. Completed libraries were quantified by qPCR us-
ing the KAPA Illumina Library Quantification Kit (Illu-
mina, USA) before multiplexing in two equimolar pools
and running on two flow cells on the Illumina NextSeq
550. Resulting FastQ files were mapped to the reference
genome (mm10) using the Tophat alignment tool (V2) on
Illumina Basespace software and reads per kilobase permil-
lion (RPKM) scores calculated for each gene. Differential
gene expression was carried out using DEseq with cut offs
of log2 fold change >2 and adjusted P-values <0.05 within
replicates applied.
H3K27me3 ChIP-seq
ChIP was performed exactly as described (24). Sequencing
libraries and Ion proton sequencing was carried out as de-
scribed for MeDIP-seq above. For details of antibodies see;
Supplementary information, Table S2.
High content western blotting – DigiWest
DigiWest was performed essentially as described in Treindl
et al. (31). Briefly; cell pellets were lysed in RIPA Buffer
containing protease Inhibitor Mix M (Serva), PhosSTOP
(Roche Applied Science) and PMSF (Thermo Scientific),
incubated for 30min on ice and proteinwas quantified using
a Pierce BCA Protein Assay Kit (Thermo Fisher Scientific).
Samples were stored at −80◦C until further use. The Nu-
PAGESDS-PAGE gel system (ThermoFisher) was used for
protein separation and blotting; 8l protein per sample was
separated using 4–12% Bis–Tris gels and transferred onto
PVDF membranes (Millipore). For high content western
analysis, the DigiWest procedure and data analysis was per-
formed as described in Treindl et al. (31). In brief; data gen-
erated by a Luminex instrument were analysed using a dedi-
cated analysis tool. To compare different samples, obtained
values were normalized to -actin; log2 transformed and
analysed in MEV 4.9.0 software. Two factor ANOVA was
performed in which factor 1 was defined as 2i treatment and
factor two as cell type (J1 versus TKO versus 3B3l). P-value
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based on 1000 permutations was set to 0.005 and hierarchi-
cal clustering based on Euclidean Distance was performed.
Significant results were plotted in a heatmap. DigiWest data
are composed of 96 individual measurements derived from
96 molecular weight fractions per sample and all values ob-
tained for a given antibody were used to create images that
mimic a Western blot image. Background subtracted Lu-
minex data were scaled to values from 0 and 1 where the
highest measured signal intensity was set to 1. Scaled data
were loaded into the MEV 4.9.0 software package, and a
graph was generated by applying a greyscale colour scheme;
0 (white) to 1 (black). Heatmaps were saved as images and
transferred to Photoshop wherein a Gaussian diffusion was
applied with a radius of half the element height. DigiWest
Luminexreads can be found in; supplementary information,
Dataset 2.
Bioinformatic processing and analysis of meDIP-Seq and
H3K27me3 ChIP-seq datasets
Mapping and data normalization. Analysis was done as de-
scribed previously (30). In short, reads were mapped to ref-
erence genome using Torrent TMAP software. Data was
binned into 200 bpwindows across the genome and normal-
ized first by total read count and then sequencing noise re-
moved by subtracting the matched input sequence (sheared
non-immunoprecipitated DNA).
Peak finding and mapping. Windows of enrichment were
defined as any 200 bp window where the signal was en-
riched over background input noise. Peaks of 5mC and
H3K27me3 were called based on threshold levels from J1-
serum cells. We defined peaks as regions where at least 2
windows (each 200 bp) in a three-window region (600 bp)
were above the 95th percentile of 5mC scores from the
J1-serum dataset. These peaks were mapped to one of
six unique genomic compartments (promoter core: TSS
±100 bp, promoter proximal: TSS + 1 kb, promoter distal:
TSS + 1 kb to + 2 kb, exonic, intronic or inter-genic: not
associated with any of the above) as defined from Refgene
annotations.
Sliding window analysis of 5mC states over regions of inter-
est. Average patterns of DNA modifications and histone
tail marks were plotted across a series of genomic features
(promoters ±2 kb, gene bodies ±25% total gene length,
Oct4/Sox2/Nanog binding sites±100% element length) us-
ing a sliding window based approach. This calculates aver-
age levels of each modification across a certain step size rel-
ative to coordinates of choice and average patterns across
these features are then plotted. Oct4/Sox2/Nanog binding
sites were taken as defined in Galonska et al. (22).
Retrotransposon analysis
J1, TKO and 3B3l mESC RNA-seq was processed as de-
scribed (24). For retrotransposon analysis, adaptors were
removed from RNA-seq reads using TrimGalore! 0.4.1
(paired end, illumina, stringency 3), and aligned to themm9
mouse genome using TopHat 2.1.0 (very sensitive, inner dis-
tance 23 ± 56, no coverage search, max multihits 1). Read
co-ordinates were intersected with UCSC genome browser
RepeatMasker track co-ordinates using BEDTools 2.25.0,
filtered to ensure that each pair or singleton was assigned to
only one repeat location, and the number of sequences be-
longing to each type of repeat summed. Repeats belonging
to LTR, LINE and SINE Repeatmasker classes that were
significantly upregulated (FDR< 0.05, logFC > 0) were
identified using the edgeR package in R. Read counts be-
tween samples were normalised relative to the number of
reads mapping to the genome.
RESULTS
mESCs reset to a naı¨ve ground state in 2i independently of
their initial epigenetic state
To investigate the role of repressive epigenetic marks in
ground state pluripotency we cultured WT, hypomethy-
lated, and constitutively methylated mESCs and analysed
their response to 2i conditions. As a hypomethylated cell
type we utilised TKO mESCs lacking functional Dnmt3a,
Dnmt3b and Dnmt1 (15). To generate constitutively methy-
lated 2i/mESCs, we utilised Dnmt3a/3b knockout mESCs
rescued by exogenous constitutive expression of Dnmt3b
andDnmt3l, as detailed in the cell line derivation schematic,
hereafter termed 3B3l (Figure 1A) (24,32). WT J1, TKO
and 3B3l mESCs were cultured in 2i medium for 14 days.
All three cell types showed characteristic mESC morpholo-
gies in serum conditions and acquired archetypal three-
dimensional dome-shaped colony morphology after 3 days
of 2i exposure (Figure 1B) (25). Expression of a key marker
of 2i transition, Prdm14, was upregulated in all three cell
lines (Figure 1C) (33). In WT JI mESCs Transcripts corre-
sponding to de novo methyltransferases (Dnmt3a, Dnmt3b
and Dnmt3l) were downregulated while the maintenance
methyltransferase (Dnmt1) remained unchanged, as ob-
served by microarray analysis and confirmed by RT-qPCR
(Figure 1C and Supplementary Figure S1a). As expected,
only theDnmt3l transcript was downregulated in TKO cells,
as the Dnmt3a, Dnmt3b and Dnmt1 genes are inactivated.
In addition, we confirmed retention ofDnmt3b andDnmt3l
transcripts in 3B3l mESCs (Figure 1C and Supplementary
Figure S1b). We also detected homogeneous expression of
Nanog and Esrrb inWT J1, TKO and 3B3l mESCs cultured
in 2i by immunocytochemistry, in contrast to heterogeneous
staining in their serum cultured counterparts (Figure 1D).
To analyse changes in DNAmethylation in WT J1, TKO
and 3B3l mESCs when converted to a 2i mediated ground
state, we performed high performance liquid chromatogra-
phy (HPLC) quantification of total 5mC levels, which re-
vealed various degrees of hypomethylation in 2i (Figure 1E).
As reported previously, 5mC levels in 2i are reduced by 50%
in WT mESCs (J1–2i) (Figure 1E). Notably, 3B3l cells cul-
tured in 2i (3B3l-2i) exhibited global DNAmethylation lev-
els equivalent to WT J1-serum cells (Figure 1E). Hence,
maintenance of Dnmt3b and Dnmt3l expression can pre-
vent cells from exhibiting global hypomethylation despite
increased Prdm14 levels during 2i adaptation (Figure 1C
and Supplementary Figure S1b). Loss of DNAmethylation
upon 2i exposure is linked with Prdm14 directed repression
ofDnmt3a/Dnmt3b/Dnmt3l or alternatively, a deficiency of
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Figure 1. J1, TKO and 3B3l mESCs achieve ground state in 2i. (A) Schematic showing cell line derivation. An expression construct for the co-factorDnmt3l
was added toDnmt3a/3b knockout mESCs rescued by exogenous constitutive expression ofDnmt3b (3B) to create aDnmt3a/3b knockout expressing both
Dnmt3l and Dnmt3b (3B3l). Dnmt3l was also added to a to Dnmt3a/3b knockout mESCs (KOVI) to create KOVI-3l. (B) Morphology images of mESCs
in indicated culture conditions. Scale bar 100 m. (C) Expression levels of indicated Dnmt’s and Prdm14. For each gene, fold change with respect to (wrt)
average J1-serum probe value is represented (as log2) with SEMs. * indicates P < 0.05 (unpaired t-test). (D) Immunocytochemistry images of indicated
conditions showing Nanog (green) and Esrrb (red) with DNA counterstaining (DAPI, blue) and merge. Scale bar 100 m. (E) HPLC quantification of
5mC levels of indicated mESCs, bars represent mean ± SD of 2–3 biological replicates. (F) Bisulfite sequencing data for indicated gene promoters and
cell lines, black: methylated CpG, grey: un-methylated CpG, white: missing data. Numbers represent percentage of methylated CpGs. * (black: methylated
CpG, grey: un-methylated CpG, white: missing data). *P < 0.05, ** P = 0.00578, two2-tailed Mann–Whitney U-test.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/doi/10.1093/nar/gkaa529/5862686 by guest on 05 July 2020
Nucleic Acids Research, 2020 7
UHRF1 and H3K9me2, required for maintenance methy-
lation (34–36). Although we observed the reported 2i in-
duced reduction of UHRF1 and H3K9me2 levels in WT
mESCs that is hypothesised to reduce Dnmt1 activity, these
alterations were not replicated in TKO-2i or 3B3l-2i mESCs
(Supplementary information, Figure S1c, d) (34). The ob-
servation that overexpression of Dnmt3b and Dnmt3l (or
deletion of Prdm14, see below) can maintain methylation
levels in 2i mESCs is incompatible with the primary role
proposed for UHRF1 in regulating global DNA methyla-
tion levels in 2imESCs (34,35). Bisulfite sequencing analysis
of loci (major satellite, Dazl and Fkbp6 promoters) known
to undergo hypomethylation in 2i demonstrated that 3B3l-
2i methylation was maintained at most of these sites (major
satellite, Dazl) or underwent a slight decrease (Fkbp6 10%
decrease, P < 0.05, two-tailed Mann–Whitney U-test), but
still remained significantly more highly methylated than in
J1–2i cells (Fkbp6 75.3% in 3B3l-2i compared with 19.7% in
J1–2i,P< 0.00001, two-tailedMann–WhitneyU-test) (Fig-
ure 1F).
To further characterize WT J1, TKO and 3B3l mESCs
cultured in 2i we performed several experiments to confirm
their pluripotency and 2i mediated signalling responses. All
three epitypes exhibit heterogeneous alkaline phosphatase
activity in serum and this increases to 100% homogeneous
alkaline phosphatase activity in mESCs cultured in 2i (Sup-
plementary information, Figure S1e). To analyse changes
in signalling pathways following 2i culture we utilised the
western blotting analysis system DigiWest to simultane-
ously assay 72 proteins (31). This confirmed the absence of
Dnmt1 protein in TKOmESCs andmaintenance ofDnmt3l
in 3B3l-2i at levels significantly above J1-2i and TKO-2i
(Supplementary information, Figure S1f). As expected, cul-
turing mESCs in 2i resulted in upregulation of -catenin,
one of the downstream targets of the GSK3 pathway and
downregulation of phospho-c-Myc, a downstream target
of the MEK pathway (Supplementary information, Figure
S1f) (25). Hence, relevant signalling pathways are intact in
all three cell lines utilised in the study. Several other pro-
teins exhibit similar expression changes in WT J1, TKO
and 3B3l mESCs based on culture conditions e.g. vimentin,
whichmay account for changes in cell shape during 2i adap-
tation (Supplementary information, Figure S1f). Moreover,
ANOVAanalysis of significant analytes (P< 0.005) resulted
in clustering of DigiWest samples according to culture con-
ditions (Supplementary information, Figure S1g, Dataset
2); implying that signal transduction pathways that respond
to 2i in WT J1, TKO and 3B3l mESCs induce similar pro-
tein expression andmodification perturbations. In addition,
we found that J1 and 3B3l mESCS were capable of forming
differentiated embryoid body (EB) outgrowths when plated
onto gelatin. TKO mESCs formed EBs but failed to form
significant outgrowths and very few cells stained positive for
-smooth muscle actin (mesodermal marker) and Tuj1 (ec-
toderm) (Supplementary information Figure S2a and data
not shown). This is in agreement with previous observations
that lack of DNA methylation in TKO mESCs leads to im-
paired differentiation to ecto- and mesoderm (18). WT J1
and 3B3l mESCs formed ectoderm and mesoderm lineages;
both generated beating cardiomyocytes staining positive for
-smooth muscle actin, as well as cells positive for Tuj1
(Supplementary information, Figure S2b). It is note-worthy
that the −smoothmuscle actin marker not only reports on
a mesodermal lineage but also attests the earliest differen-
tiation from pluripotent mouse ESCs into mesendoderm,
(ME) the intermediate stage equivalent to the embryonic
primitive streak, fromwhich bothmesoderm and endoderm
are derived (37). However, we did not observe significant
endodermal marker expression for either cell type with this
differentiation protocol; perhaps indicating that a more di-
rected differentiation approach may be required to generate
this lineage with these cell lines (data not shown). In addi-
tion, WT J1 and 3B3l mESCs both generated a stable epi-
blast stem cell line when treated with appropriate cytokines,
however TKO mESCs were unable to differentiate to this
lineage (Supplementary information, Figure S2c). Taken to-
gether this data suggests that 3B3l mESCs can transition to
a naive ground state and differentiate into specialised cell
types unlike TKO cells, which are differentiation impaired.
In order to investigate alterations in repressive chromatin
marks in response to DNA methylation changes and 2i
signalling we performed immunocytochemistry (ICC) for
H3K27me3 and H2AK119ub in WT J1, TKO and 3B3l
mESCs cultured in serum and 2i, as well as in early and
late blastocysts. As reported previously, both H3K27me3
and H2AK119ub are redirected to pericentric heterochro-
matin (PCH) in a high proportion of TKO cells under serum
conditions (Figure 2A) (38). A similar proportion exhib-
ited PCH localisation for both modifications in TKO-2i
cells (Figure 2A). In contrast, no significant PCH asso-
ciation of H3K27me3 and H2AK119ub was observed in
J1-2i or 3B3l-2i cells (Figure 2B; Supplementary informa-
tion, Figure S3). This contrasts with a recent report sug-
gesting that 2i-ESCs are distinguished from other pluripo-
tent cells by a prominent enrichment in H3K27me3 and
low levels of DNA methylation at PCH (39). However we
note that Tosolini and colleagues culture their 2i-mESCs on
Laminin which also leads to the appearence of H3K27me3
in conjunction with H3K9me3 at PCH in serum grown
mESCs, whereas we follow the original SOP of Ying et al.
and grow ESCs on gelatin coated plastic (25). It is possi-
ble that the ability of Lamins to confer proliferative stim-
ulation on mESCs may cause additional changes that af-
fect H3K27me3 deposition when mESCs are transitioned
to 2i (40). To verify the situation in vivo, we isolated blas-
tocyst stage embryos and stained them for H3K27me3 (9).
Early and late male blastocysts show a marked increase
in H3K27me3 levels in the ICM, in contrast to very low
trophectoderm (TE) levels (Figure 2C). Early ICM pat-
terns display euchromatic distribution away from DNA-
dense foci similar to WT J1 mESCs. This pattern is main-
tained in the epiblast; however, in some cells of the late ICM
margin proximal to the blastocoele, H3K27me3 foci colo-
calise with regions of high DNA density in a pattern simi-
lar to TKOcells (Figure 2C). This indicates redistribution of
H3K27me3 might be a response to developmental cues that
involvesDNAhypomethylation of the ICM (41,42). During
themeiotic prophase of spermatogenesis,H3K27me3 is also
observed to accumulate on PCH from the mid pachytene
stage onward, during which DNA methylation reprogram-
ming occurs as evidenced by hyomethylated minor satellite
repeats (43,44).
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Figure 2. Epigenetic state of heterochromatin in mESCs and H3K27me3 dynamics during mouse blastocyst development. (A, B) ICC of H3K27me3
(green) and H2AK119Ubiquitin (green) in indicated cells with DAPI (blue) and merge (turquoise represents overlapping signal). White outlined nuclei
are ‘zoomed in’ images of representative nuclei. Numbers represent the percentage of cells where green foci overlap with DAPI stained heterochromatin.
Scale bar 50 m. (C) ICC for H3K27me3 (green) with DAPI (pseudocoloured red). Whole and part embryo confocal projections and highlighted cells
from the inner ICM and the ICM margin (yellow represents overlapping signal), as indicated; scale bars 10 m. Arrowheads indicate three cells showing
heterochromatic H3K27me3 staining.
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Inhibition ofMEK1/2 and GSK3 is necessary to drive TKO
cells to the naı¨ve state
As a reduction in DNAmethylation has been postulated to
be a hallmark of the naı¨ve state, we analysed TKO mESCs
to address whether they would convert more easily to the
ground state than WT mESCs. We checked the sensitivity
of J1 and TKO cells to the two inhibitors at various dilu-
tions in defined media (SFES) with a constant LIF con-
centration. Both cell lines responded comparably and nei-
ther achieved ground statemorphology when cultured in di-
luted 2i medium (Supplementary information, Figure S4a).
We observed comparable trends in key transcript changes
in both J1 and TKO mESCs in diluted 2i, but alterations
were not to the same extent as in complete 2i (Supplemen-
tary information, Figure S4b). We also evaluated the effect
of individual inhibitors, PD0325901 andCHIR99021. TKO
cells acquired a 3D-dome shaped colony morphology sim-
ilar to 2i adaptation, upon exposure to CHIR99021 + LIF
(CH), while exhibiting very distinct needle-shaped flat cell
morphology upon PD0325901 + LIF (PD) treatment (Sup-
plementary information, Figure S4c, d). Nanog expression
was lower in TKO cells incubated with CH alone compared
to PD or 2i cultured cells (Supplementary information, Fig-
ure S4e). Prolonged culture in no inhibitor medium (SFES)
or single inhibitor (CH or PD) resulted in decreased cell
viability and spontaneous differentiation compared to 2i
cells, in agreement with reports for WT cells (Supplemen-
tary information, Figure S4d) (25). Associated gene expres-
sion changes (notably Dnmt3l, Eomes and Lin28a) did not
occur to the same extent with single inhibitors as compared
to inhibiting both pathways (Supplementary information,
Figure S4f).
As Prdm14 is suggested to be a key player in driving
cells to the 2i ground state, we generated a TET-inducible
Prdm14 TKO mESC line to test if its overexpression in hy-
pomethylatedmESCs is sufficient to drive thesemESCs into
a ground state (Supplementary information, Figure S5a, b)
(35). Upon induction of Prdm14 nomorphological changes
were observed in TET-ON-Prdm14 TKO clones (Supple-
mentary information, Figure S5c). Additionally, although
direct targets of Prdm14 such as Dnmt3l and Lefty2 were
down regulated, we did not observe transcript changes as-
sociated with 2i adaptation such as upregulation of Dmgdh
(highest expression change in 2i versus serum in wild-type
mESCs) or Eomes (stem cell maintenance gene) and down-
regulation of Pax6 and Fgf15 (differentiation genes), in
any of the TET-ON-Prdm14 TKO clones irrespective of
the level of Prdm14 overexpression (Supplementary infor-
mation, Figure S5d) (45). This suggests Prdm14 upregula-
tion and 5mC depletion alone is not sufficient to reprogram
serum cultured mESCs to a ground state in terms of mor-
phology (Supplementary information, Figure S5c) or gene
expression (Supplementary information, Figure S5d).
Gene expression patterns are determined by culture condi-
tions
In order to delineate gene expression changes caused by 2i
signalling from gene expression changes caused by a dif-
ference in DNA methylation, we analysed gene expression
in WT J1, TKO and 3B3l mESCs cultured in serum and
2i. Pearson correlation analysis of expression profiles re-
vealed robust clustering based on culture conditions rather
than genotype (Figure 3A). The number of differentially ex-
pressed genes between TKO and WT J1 mESCs in 2i com-
pared to serum culture conditions is reduced and consoli-
dates as 3.3 times less upregulated and 2.9 times less down-
regulated genes (Supplementary information, Figure S6a,
b). Moreover, in spite of being hypomethylated in 2i, the
transcriptome of WT J1-2i mESCs differs greatly from that
of TKO-serum (Supplementary information, Figure S6c).
In agreement with previous reports, we observed a large
number of genes (>3500) differentially expressed in 2i wild-
type cells compared to serum conditions (1823 up- and
2208 down-regulated, fold change≥2,P.adj.≤ 0.05, eBayes
(limma), Benjamini–Hochberg corrected) (Figure 3B; Sup-
plementary information, Dataset 1) (13,35,46). There is an
overlap of 843 genes between all three 2i cell lines that exhib-
ited similar changes in expression (318 up- and 525 down-
regulated) (Figure 3b; Supplementary information, Dataset
1). Moreover, transcription factors associated with naı¨ve
pluripotency are upregulated in WT J1, TKO and 3B3l in
2i compared to respective serum cells; with the exception of
Klf2which exhibited increased expression in TKO and 3B3l
mESCs in serum (Figure 3C). Importantly, these factors are
equivalently expressed in all three epitypes in 2i. Functional
pathway analysis of the common gene list upregulated in 2i
revealed enrichment of genes related to germ cell and em-
bryonic development, while genes downregulated in 2i are
linked with differentiation (Figure 3D). Based on pathway
analysis, we focused on genes associated with the GO terms
‘Cell Fate Commitment’ (CFC: GO:0045165) and ‘Stem
Cell Maintenance’ (SCM: GO:0019827), which were differ-
entially expressed (FC ≥ 1.5, P.adj< 0.05, eBayes (limma),
Benjamini–Hochberg corrected) betweenWT J1-serum and
J1-2i mESCs. These gene sets showed a similar trend in
TKO and 3B3l mESCs following adaptation to 2i (Figure
3E, F; Supplementary information, Figures S6d and S7)
and we also observed this in WT and Prdm14−/− mESCs,
(Supplementary information, Figure S6e, f) (35). In addi-
tion, hierarchical clustering analysis linked these cell types
together based on culture condition rather than genotype
(Supplementary information, Figure S6g). Our results em-
phasize that mESCs can achieve a ‘transcriptional ground
state’ in 2i through enhanced expression of a number of
pluripotency associated genes, including Nanog, Esrrb and
Klf4, irrespective of global methylation status, and that hy-
pomethylation is dispensable for this transition (Figure 3F).
Epigenetic changes in the 2i mediated ground state
To study functional consequences of DNA methylation re-
arrangement in the reprogramming of mESCs to ground
state, we generated genome-wide patterns of 5mC inWT J1
and 3B3l mESCs cultured in serum and 2i by genome wide
MeDIP-seq assays (30). We validated the levels of 5mC en-
richment across the genome in J1 and 3B3l epitypes and re-
port upon an ∼50% reduction in the number of both 5mC
enriched loci (termed windows, see material and methods)
and HPLC quantified 5mC scores in J1-2i mESCs (Fig-
ures 1E and 4A). The number of enriched windows in 3B3l-
serumwas similar to those inWT J1-serum; as expected this
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Figure 3. Gene expression changes in mESCs upon culturing in 2i. (A) Heatmap showing Pearson correlation and clustering of microarray data for
indicated cell lines and culture conditions. (B) Venn diagram showing the number of genes changing in expression (FC ≥ 2, P.adj. ≤ 0.05 eBayes (limma),
Benjamini–Hochberg corrected) in J1-2i (red), TKO-2i (green) and 3B3l-2i (yellow) compared to their serum counterparts. (C) Log2 expression values of
indicated genes in mESCs in serum and 2i. Bars represent mean ± SD. * indicates P < 0.05 (unpaired t-test). (D) GO-Term analysis showing genes up- or
down-regulated in J1, TKO and 3B3l mESCs. (E), Heatmap representing expression levels of ‘Cell Fate Commitment’ genes differentially expressed (FC ≥
1.5, p.adj. ≤ 0.05 eBayes (limma), Benjamini-Hochberg corrected) in J1-2i compared to J1-serum in indicated cells. * marks genes which are differentially
expressed (FC ≥ 2, P.adj. ≤ 0.05 eBayes (limma), Benjamini–Hochberg corrected) between TKO-serum and J1-serum. (F), Same as E for ‘Stem Cell
Maintenance’ genes.
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Figure 4. 5mC and H3K27me3 modifications in J1, 3B3l and TKO mESCs in serum and 2i. (A) Windows enriched in 5mC relative to input sequence for
indicated cell lines and conditions. (B) Fluorescent western blot of whole cell protein extracts showing levels of H3K27me3 for indicated cell lines cultured
in serum or 2i. -tubulin was used as a loading control. (C) Total number of 5mC peaks (see materials and methods) for indicated cell lines and conditions.
(D) Heatmap indicating 5mC (red) and H3K27me3 (purple) levels; 0–10, see scale, for indicated cell lines and conditions across indicated genomic features,
covering regions as described. Q4-Q1 indicates low to high gene expression. (E) Sliding window analysis of average genic 5mC patterns across indicated
cell lines. Plots represent length normalised gene bodies with flanking regions (±25% of total gene length). Stratification of genic patterns by promoter
5mC enrichment (upper box) or depletion (lower box). Numbers of genes per set are shown above. (F) Boxplots representing average H3K27me3 signal
on promoters (±1 kb from TSS) for all promoters or promoters preferentially losing H3K27me3 in TKO-2i relative to TKO-serum. * indicates P <
0.05 (Wilcoxon test). (G) Heatmap representing normalised H3K27me3 reads across promoters (±5 kb TSS). Bottom graphs represent averaged profiles.
Heatmaps are ranked by E14 serum levels. (H) Examples of H3K27me3 pattern across Neurog3, Hoxc13, 12, 11 and Tbx3 for indicated cell lines and
culture conditions.
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cell line did not exhibit the typical loss of 5mC upon 2i ex-
posure (Figure 4A). Interestingly, although global levels of
5mC differ between the epitypes upon transition to ground
state, by western blot there was no obvious change in total
H3K27me3 levels in WT J1 and 3B3l mESCs in serum or 2i
in agreement with two reports, but H3K27me3 levels were
higher in TKO-2i cells (Figure 4B) (13,39). In contrast, a re-
cent proteomic study found higher H3K27me3 levels inWT
mESCs cultured in 2i conditions; despite this they also re-
port, by ChIP-seq, a redistribution of H3K27me3 profiles
in 2i culture conditions (23). Although we report an overall
reduction in 5mC levels within these cells (as evident from
a drop of 5mC peaks to 4.7% in the J1-21 cells with respect
to the serum state. Figure 4C), the underlying genomic pat-
terns remain largely unchanged (Figure 4D; Supplementary
information, Figure S8a, b)
To refine our assessment, we interrogated 5mC and
H3K27me3 patterns across a number of functional genomic
compartments (Figure 4). Focusing first on promoter and
gene body regions, we discovered that although levels and
patterns of 5mC are lost upon transition to 2i in WT J1
cells, these are maintained across the same sets of promot-
ers and gene bodies in J1-serum, 3B3l-serum and 3B3l-2i
mESCs (Figure 4A andC–E). Analysis of locus specific pat-
terns also revealed that 5mCmarked promoters identified in
WT J1 serummESCs remain similarlymarked in both 3B3l-
serum and 2i cells (Figure 4D, E). To analyse H3K27me3
patterns we utilized a published E14 mESC dataset as our
WT reference data (GSE23943) as their deposition at biva-
lent promoters is reported to be dependent on global DNA
methylation levels (13,42,47). H3K27me3 patterns are typ-
ically reduced upon transition to 2i in WT E14 mESCs
but broadly maintained over promoter and genic regions
in the constitutively methylated cell line in 2i (Figure 4D,
F). To delineate 5mC mediated changes from 2i signalling
changes in H3K27me3 distribution; we compared patterns
of H3K27me3 between TKO-serum and TKO-2i mESCs.
Interestingly, we note a reduction in the H3K27me3 sig-
nal, which manifests in loss from a number of promoter el-
ements (Figure 4F, G). Stratification of the total promoter
set based on regions which lose H3K27me3 between TKO-
serum and TKO-2i revealed a subset of 2i specific, DNA
methylation independent regulation loci across all epitypes
(Figure 4F). Visualization of these loci (specific examples;
Neurog3, Hoxc12–13 and Tbx3) uncovered a strong loss
of H3K27me3 levels in 2i conditions irrespective of global
DNA methylation state––highlighting a small set of com-
mon 2i signalling induced epigenetic changes in all three
mESC epitypes (Figure 4H).
Analysis over enhancer and pluripotency factor binding
elements revealed that such loci are typically depleted in
5mC and H3K27me3 in both serum and 2i conditions for
all three epitypes (Figure 4D; Supplementary information,
Figure S8b) (22). Analysis over annotated replication origin
sites revealed a general loss of 5mC in WT J1-2i conditions
but higher levels of 5mC atmedium and late replicating sites
in bothWT J1-serum, 3B3l-serum and 3B3l-2i mESCs (Fig-
ure 4D) (48). Similarly, there is a general loss of H3K27me3
in WT E14-2i cells with higher levels of H3K27me3 present
in early replication origins in WT E14-serum, 3B3l-serum
and 3B3l-2i lines (Figure 4D). Additionally, DNA methy-
lation is lost at repeat sequences (including major satellite
and LINE-1 retrotransposons) in WT J1-2i but maintained
in 3B3l-2i mESCs (Figure 4D).
Analysis of RNA-seq data for WT J1, TKO and 3B3l
mESCs cultured in serum and 2i revealed that some differ-
ences exist between culture conditions and epitypes tested
in terms of retrotransposon expression (Supplementary in-
formation, Figure S8c–f). Consistent with previous ob-
servations, retrotransposon derepression in response to 2i
or changes in DNA methylation was relatively modest
in mESCs (Supplementary information, Figure S8c), and
smaller in magnitude than observed for differentially ex-
pressed genes (49–51). A subset of 44 (28%) of the 156 retro-
transposons upregulated when WT J1 mESCs transition
from serum to 2i is also upregulated when TKO and 3B3l
mESCs transition from serum to 2i (Supplementary infor-
mation, Figure S8d). These retrotransposons, which include
RLTR13B2::ETNERV3-int and RLTR44C::RLTR44-int
long terminal repeats and associated internal sequences,
are upregulated in 2i regardless of methylation state (Sup-
plementary information, Figure S8f). Some elements in
this subset, such as RLTR10D::IAP-d-int, appear to ex-
hibit a combinatorial response to 2i and DNA methylation
such that they are upregulated in response to hypomethy-
lation and further upregulated in response to 2i (Supple-
mentary information, Figure S8f). These elements exhibit
similar behaviour to Dazl and Fkbp6 genes (Figure 5B), al-
though it is also possible that the mixed response of these
elements reflects distinct responses of individual genomic
copies of that repeat. Interestingly, most (149 of 203) of
the retrotransposons that are upregulated in response to
DNA hypomethylation in serum-cultured mESCs, includ-
ing RLTR44B and MMERVK10D3 LTR, are not upreg-
ulated when WT J1 mESCs transition from serum to 2i
(Supplementary information, Figure S8e, f). Thus, different
retrotransposons respond to the 2i environment, changes
in DNA methylation, or a combination of both in mESCs.
Finally, imprinted loci exhibit a greater level of both 5mC
and H3K27me3 retention during 2i reprogramming in
both WT J1 and 3B3l mESCs, arguing that maintenance
of 5mC levels may be functionally required at such sites
(Figure 4D).
Analysis of epigenetic changes over transcriptionally altered
genes
As we observed a consistent change in transcription in all
three epitypes when converted to 2i mediated ground state,
we set out to elucidate whether specific changes to 5mC and
H3K27me3 may be fundamental drivers of these changes.
For the total arrayed gene set for all three cell types as well
as for gene sets exhibiting strong changes in gene expres-
sion when cultured in 2i versus serum, we did not detect
a relationship between alterations in promoter 5mC levels
and the expression status of linked genes (Figure 5A& Sup-
plementary information, Figure S9a). To validate this re-
sult, we selected two candidate methylation regulated genes;
Dazl and Fkbp6, and examined the effect of 2i signalling
on their expression in WT J1, TKO and 3B3l mESCs by
RT-qPCR (Figure 5B) (13,52). These two transcripts are
highly upregulated in TKO compared to WT J1 mESCs,
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Figure 5. Epigenetic changes over transcriptionally altered genes in mESCs in serum and 2i. (A) Boxplots of average promoter 5mC in indicated cell lines
over the total gene set, genes expressed under 2i conditions and genes repressed under 2i conditions. * indicates P < 0.05 (Wilcoxon test). (B) Examples of
5mC data at the promoters of the methylation regulated genes Dazl and Fkbp6 alongside RT-qPCR data for serum and 2i conditions. Promoter regions
are marked by grey shadows. Barcharts show expression analysis of indicated genes by RT-qPCR, values represent mean ± SD of expression with respect
to (wrt) TBP. * indicates P < 0.05 (unpaired t-test). (C) Scatter plot of fold change in expression 2i-serum (y-axis) versus fold change in average genic
H3K27me3 levels (2i-serum) in WT (left), 3B3l (centre) and TKO (right) cells. Yellow = 2i induced genes, blue = 2i repressed genes. (D) Boxplot detailing
expression changes serum to 2i (log2 fold changes) across WT, TKO, 3B3l, Eed−/− and EPZ6438 treatedDnmt1tet/tetmESCs. Left: genes with overlapping
H3K27me3 loss/expression gain in J1/TKO/3B3l mESCs. Right: genes with overlapping H3K27me3 gain/expression loss in J1/TKO/3B3l mESCs.
supporting a role for promoter demethylation in their up-
regulation. However, they are both further upregulated in
2i in TKO and 3B3l mESCs and we observed comparable
changes in Dazl protein levels by DigiWest analysis (Figure
5b and Supplementary information, Figure S9b). The pro-
moters of these genes exhibited demethylation in WT J1-2i
but maintained DNA methylation in 3B3l-2i as evidenced
by meDIP and locus-specific bisulfite sequencing (Figures
5B and 1F). Hence, at transcript level, regardless of whether
their promoters were hypomethylated or hypermethylated,
both Dazl and Fkbp6 responded in the same way to 2i sig-
nalling, resembling what we observed for a subset of 2i me-
diated changes in DNA repeat expression (Figure 5b and
Supplementary information, Figure S8c–f).
We did observe a relationship between loss of H3K27me3
from genic regions of genes transcriptionally induced in
2i in all three epitypes; a relationship which was not ob-
served over transcriptionally repressed genes (Figure 5C).
To test whether these genes are regulated by 2i mediated
signalling, we assayed their expression levels in mESCs
with altered H3K27me3 levels; mESCs exposed to an in-
hibitor of the polycomb protein, EZH2 methyltransferase
(EPZ6438), or through analysis of published expression
data from polycomb regulatory complex mutant mESCs
(Eed−/−) (53,54). We found that 2i induced genes, which
lost H3K27me3 in WT, 3B3l and TKO mESCs, were not
induced in these H3K27me3 perturbed serum cultured cells
(Figure 5D; Supplementary information Figure S10), indi-
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cating that changes in expression of these genes are also di-
rect consequences of 2i signalling and not due to changes in
H3K27me3 deposition.
Relationship between gene regulatory network and epigenetic
landscape
A recent study has shown that the differential binding of
a core network of the pluripotency factors Oct4, Sox2 and
Nanog (OSN) is important in reaching ground state follow-
ing 2i exposure (22). However, it is not known how the epi-
genetic landscapes at these key regulatory sites are related
to factor binding events and establishment of specific gene
regulatory networks. We first set out to elucidate how the
transcriptional landscape at genes near differentially bound
OSN sites is affected during 2i transition by identifying the
nearest neighbouring gene (first gene within 10 kb of an el-
evated or reduced OSN site in 2i, referred to as distal el-
ements) and analysed their expression changes in our cell
panel. We discovered a similar number of distal genes that
are induced and repressed near 2i specific OSN sites upon
2i conversion but observed a large reduction in transcrip-
tion at distal genes where OSN factors are reduced in 2i,
arguing that transcription from a subset of genes is linked
to binding of distal factors (Figure 6A and Supplementary
information, Figure S11a).When we rank 2i driven changes
in gene expression at these distal genes inWT J1mESCs (i.e.
log2 FC J1-serum> J1-2i, Supplementary Figure S11a), we
observe similar transcriptomic changes following 2i conver-
sion in WT J1, 3B3l and TKO mESCs (Figure 6A, Supple-
mentary information, Figure S11a, b).
Enhancer elements and OSN binding sites are typically
DNA hypomethylated, including in 3B3l mESCs. We there-
fore tested the hypothesis that active DNA demethylation
could play a key role in the maintenance of this epige-
netic state and that if perturbed would affect constitutively
methylated mESCs to a greater degree than WT cells, po-
tentially abrogating their ability to reach ground state. To
do so we used an siRNA approach to reduce the levels of
the DNA demethylation machinery members Tet1 and Tet2
in WT J1 and 3B3l mESCs cultured in serum or for 24 h
in 2i (see Materials and Methods). Compared to scrambled
siRNA controls, transfection of published siRNAs against
Tet1 and Tet2 (Supplementary information, Figure S11c)
was sufficient to reduce the 5hmC signal in these cells to un-
detectable levels by immunocytochemistry (Figure 6B) (55).
This did not interfere with cell viability as evaluated bymor-
phology, Esrrb staining or pluripotency marker expression
assessed by qRT-PCR, indicating the 5hmC pathway was
not required for the serum to 2i transition in WT J1 and
3B3l mESCs (Figure 6B, C).
DISCUSSION
In this paper, we address some widely held assumptions
regarding the epigenetic identity of ground state ES cells
(56). Early observations reported that the transition of ES
cells to ground state, dependent on ground state promot-
ing signalling pathways, is accompanied by a reduction in
DNAmethylation levels (20,33). This major epigenetic state
change, which also involves altered H3K27me3 deposition,
was viewed as integral to the cells functional transition
through gene expression changes (13). Surprisingly, how-
ever, this premise had not been fully tested. Our study re-
ports three unexpected important new insights: the reduc-
tion in DNA methylation is not a prerequisite for ES cells
to achieve the ground state transition; this global DNA hy-
pomethylation does not lead to transcription alterations of
the genes undergoing demethylation; and H3K27me3 re-
distribution induced by the reduction in DNA methylation
does not lead to transcription changes of the genes affected,
which are dependent on changes in transcriptional factor
networks (22). Our conclusions obtained by a novel route of
comparing serum to 2i transitions of wild type, hypomethy-
lated and constitutively DNA methylated mESCs, are in
alignment with work using PRC2 deficient mESCs that de-
fined 2i induced transcription factor and proteomic changes
respectively (22,23). These papers showed that PRC2 func-
tion is not required formESCpluripotency, self renewal and
the 2i transition. Significantly VanMierlo et al. also observe
in 2i cultured PRC2 deficient mESCs a relative increase in
DNAmethylation levels that appears to be due to enhanced
protein expression of Dnmt3a, Dnmt3b and Dnmt3l (23).
This observation again challenges the view that it is pertur-
bation of the Dnmt1/Uhrf1 axis that is responsible for hy-
pomethylation in 2i cultured mESCs (34). Consistent with
a direct impact of PRC2 deficiency on DNA methylation
levels in 2i cultured mESCs, hypermethylation is also ob-
served at the CGI shores of a distinct class of bivalent genes
in serum/LIF cultured PRC1/2 mutant mESCs (42). This
implies that DNA methylation and Polycomb, two distinct
epigenetic repression systems, have direct as well as indi-
rect impacts on each other. Collectively our data and data
from Van Mierlo et al. and Galonska et al. support the
view that during the 2i transition changes in H3K27me3
and/or DNA methylation are secondary effects, which do
not influence specific gene expression in 2i mESCs (22,23).
These conclusions raise the question to what extent the epi-
genetic state of a cell defines its identity. In the case of em-
bryonic stem cells the answer points to an epigenetic ground
state that is decoupled from the pluripotency ground state,
with both the gene regulatory network and the epigenetic
network poised to interconnect at or after differentiation.
Of relevance here is the previous suggestion that enhanced
germline gene expression in ground state mESCs is primar-
ily a consequence of global DNA hypomethylation (49). We
tested this premise and found that patterns of gene expres-
sion including germline, are similarly dependent on 2i cul-
ture conditions, and occur independently of DNA methy-
lation status. Our observations imply that global reduction
of 5mC is not required for gene regulatory networks to or-
chestrate changes in transcription resulting in altered stem
cell states. This is in line with the observation that in some
species extensive reprogramming of DNA methylation in
early embryogenesis is not observed (57,58).
H3K27me3 regulated gene expression
All three mESC epitypes showed similar morphological
changes, enhanced expression of pluripotency factors and
signalling induced changes at a discrete set of H3K27me3
marked genes (e.g. Tbx3, Hoxc12 and Hoxc13). Notably,
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Figure 6. Relationship between, gene regulatory networks, epigenetic marks and culture conditions in mESCs. (A) Z-score normalised heatmaps ranked
by relative expression level of the nearest gene to an OSN binding site (within ±10 kb) with increased binding in 2i (top) or increased binding in serum
(bottom) for indicated cell lines. Hierarchical clustering groups by culture condition. (B, C) siRNA knockdown of Tet1 and Tet2 for indicated cell lines. (B)
Immunocytochemistry for indicated cell lines. Scale bar is 100m. Left: DAPI (blue), 5hmC (green) and merge. Right: DAPI (blue), Esrrb (green), Tet1
(yellow), Cy3-siRNA (red) and merge. (C) Expression analysis of indicated genes by RT-qPCR in J1–36 (blue) and 3B3l (orange) mESCs in 72 h serum or
48 h serum + 24 h 2i transfected with either scrambled siRNA or siRNAs for Tet1 + Tet2. Values represent mean ± S.D. of three technical replicates with
respect to (wrt) to the housekeeping gene TBP (TATA Binding Protein), normalized to serum siScrambled values.
expression of these H3K27me3 marked genes was not ac-
tivated in serum in the absence of polycomb repression.
This agrees with our recent work on the identification of
DNA methylation mediated changes in chromatin com-
paction that occurs when WT mESCs are shifted from
serum to 2i growth conditions (24). Chromatin decom-
paction at polycombmarked regions is prevented in 3B3l-2i
mESCs when global DNA methylation is maintained, but
inhibition of decompaction also does not appear to have
phenotypic consequences. Similarly, polycomb dependent
chromatin compaction in hypomethylated TKO cells is pre-
dicted to be already altered in serum conditions, but, as
we have shown, does not significantly impact on the abil-
ity of these cells to transition to a ground state under 2i
conditions. These observations support the idea that DNA
methylation and polycomb processes are not instrumen-
tal for the transition of mESCs to a ground state (22,59).
It is noteworthy that during early cleavage-stage mouse
embryos, H3K27me3 is absent from promoters under hy-
pomethylated conditions (42,60). It is only later that biva-
lent domains (H3K4me3/H3K27me3) and topological as-
sociated domains are newly established in the inner cell
mass/trophectoderm,which constitutes the chromatin envi-
ronment that supports the gene regulatory networks neces-
sary for subsequent development (60,61). Our results widen
the impact of the observation that H3K27me3 is dispens-
able for repression of bivalent genes and de novo silencing
in 2i (22).
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DNA methylation regulated gene expression
Our data provide a set of core transcriptomic changes that
occur independently of methylation in the conversion of
mESCs to the ground state. Despite hypomethylated TKO-
serum mESCs showing some intermediate gene expression
states, they firmly cluster with WT-serum mESCs and have
no less requirement for 2i signalling for conversion to a uni-
form ground state. Our orthologous experiments demon-
strate that constitutive DNA methylation is also not an im-
pediment to 2i adaptation. The impact of DNA methyla-
tion loss at promoter regions is relatively restricted here,
but even at bona fide methylation dependent genes (Dazl
and Fkbp6), their induction in 2i conditions occurs in-
dependently of whether their promoters are constitutively
hypomethylated or methylated. The promoter methylation
that can be directly overridden in mESCs contrasts with ob-
servations of its inhibitory effect in somatic cells to date,
and needs further investigation of these different cellular
contexts (52). Changes in retrotransposon expression in re-
sponse to hypomethylation or 2i signalling are not dra-
matic in contrast to retrotransposon derepression in hy-
pomethylated somatic cells, or mESCs defective in Setdb1-
dependent histone methylation (29,50,51). Tellingly, neither
Prdm14 inactivation in WT cells, nor its overexpression in
TKOmESCs affects 2imediated transition to the naı¨ve state
(35). Prdm14−/− mESCs in 2i exhibit global levels of DNA
methylation comparable to WT mESCs cultured in serum,
which offers strong support that Prdm14 is a key driver of
DNA demethylation in 2i cultures, and not inhibition of
Dnmt1 activity by a deficiency of UHRF1 and H3K9me2
factors (20,26,34). Analysis of changes in gene subsets re-
lated to stem cell maintenance and cell fate commitment
in microarray data from Prdm14−/− and WT mESCs in 2i
with hierarchical clustering of these datasets are in complete
agreement with the present study suggesting that the role
of Prdm14 in antagonising FGFR signalling and repres-
sion of de novo Dnmt enzymes maybe incidental to ground
state conversion (20). The characteristic changes that 3B3l
mESCs undergo in 2i in terms of morphology, pluripo-
tency marker homogeneity and gene expression changes in
stem cell maintenance and cell fate commitment gene sub-
sets supports this view. This indicates that serum/LIF as-
sociated patterns of DNA methylation and H3K27me3 are
compatible with the 2i state. In addition, OSN enhancers
associated with canonical Wnt and ERK signalling path-
ways appear to function equivalently in all three epitypes
and in the case of 3B3l mESCs did not depend on Tet me-
diated demethylation for activity in 2i conditions. We con-
clude that reorganisation of core pluripotency factors in 2i
is independent of the global epigenetic (DNA methylation
and H3K27me3) state of the cells.
Our results raise new hypotheses regarding the role of
DNA methylation and PRC2 (Polycomb Repressive Com-
plex 2) in the 2i transition. In the blastocyst embryo, the
early ICM state exists during a short-lived window in the
lead-up to embryonic differentiation or the derivation of
mESC lines, which are thought to acquire late epiblast char-
acteristics in in vitro cultures (9). This is accompanied by
higher levels of DNA methylation, more restricted Prdm14
expression, fluctuating pluripotency gene expression and
emergence of differentiation marks and heterochromatin
maturationmarks as well as a shorter cell cycle time (10,62).
From this perspective, the conversion of serum mESCs to
2i conditions can be regarded as a reprogramming of these
cells to an earlier pluripotent state, which does not main-
tain these late markers, but their presence is not a hindrance
to regaining a 2i mediated ground state. This may be espe-
cially relevant to redefining the hallmarks of naı¨ve pluripo-
tency in othermammals thatmay have distinct developmen-
tal epigenetic reprogramming patterns (14). In mouse early
preimplantation embryos, a state of low DNA methylation
is actively and passively maintained through mechanisms
of DNAdemethylation, Dnmt1 exclusion, cell division, and
Prdm14 expression, while chromatin is dynamic and more
dispersed (60,61,63). The organisation of condensed chro-
matin domains and chromocenters appears after implanta-
tion and also in epiblast stem cells, for which DNA methy-
lation is required (63).
We propose that global hypomethylation is a conse-
quence of transcriptional and signalling changes in 2i
medium, but is not essential for adaptation of mESCs to the
‘transcriptional ground state’ as defined by core transcrip-
tion changes that occur irrespective of methylation in the
conversion of mESCs to the ground state. This implies that
signalling induced gene regulatory networks, and not epi-
genetic mechanisms, dominate to regulate transcriptional
changes required for mESCs to achieve ground state. This is
compatible with studies showing that inactivation of many
epigenetic regulators (Ezh2, Eed, Dnmt1, Uhrf1, Ring1b,
G9a, Glp, (Suv39h1 and Suv39h2), Jarid1b and Tet1–3) is
compatible with development up to blastocyst stages and
derivation of self-renewing mESCs but incompatible with
later stages of development when pluripotency networks are
attenuated and alternative differentiation associated GRNs
are prominent (64). It is clear that altered patterns of DNA
methylation and polycomb in the naive state do not de-
fine its identity through gene regulation but may reflect ge-
nomic reprogramming to earlier patterns present in pre-
blastocyst embryos, with 2i conditions reversing chromatin
transitions that may develop into the epigenetic control of
gene expression in differentiated cells. A key question is,
when do these repressive epigenetic pathways become op-
erational and possibly outweigh signalling cues, and what
roles do these early transitions play in subsequent differ-
entiation to stable somatic lineage identities. It is plausible
that this is linked with core transcription factor changes en-
abling essential regulatory roles for epigenetic processes in
coordinating and maintaining differential patterns of gene
expression.
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